Maven Securities LTD Amgen Inc Transaction History

Maven Securities LTD

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 12, 2024	BUY	$255.7 - $288.46 $1.24 Million - $1.4 Million	4,859 New	4,859 $1.4 Million
Q2 2023 Aug 04, 2023	BUY	$214.27 - $253.37 $829,224 - $980,541	3,870 New	3,870 $859,000
Q3 2022 Nov 14, 2022	BUY	$224.46 - $253.15 $1.45 Million - $1.63 Million	6,454 New	6,454 $14.5 Million
Q1 2022 May 16, 2022	SELL	$219.27 - $242.57 $511,337 - $565,673	-2,332 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$198.88 - $227.6 $463,788 - $530,763	2,332 New	2,332 $525,000
Q2 2021 Aug 16, 2021	SELL	$233.58 - $259.14 $606,140 - $672,468	-2,595 Closed	0 $0
Q1 2021 May 17, 2021	SELL	$221.91 - $258.6 $633,996 - $738,820	-2,857 Reduced 52.4%	2,595 $645,000
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $538,786 - $641,598	2,490 Added 84.06%	5,452 $1.25 Million
Q3 2020 Nov 13, 2020	BUY	$234.65 - $260.95 $58,897 - $65,498	251 Added 9.26%	2,962 $748,000
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $536,262 - $658,068	2,711 New	2,711 $639,000
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $204,157 - $262,412	-1,079 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$174.11 - $208.62 $187,864 - $225,100	1,079 New	1,079 $210,000

3,075

417M

7.19M

6.28M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Maven Securities LTD, based on Form 13F filings with the SEC.

Stay updated on Maven Securities LTD with notifications on news.